Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States

Detalles Bibliográficos
Autores principales: Peng, Terrance, Hamann, Heidi A., David, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983342/
https://www.ncbi.nlm.nih.gov/pubmed/35400082
http://dx.doi.org/10.1016/j.jtocrr.2022.100302
_version_ 1784681965978386432
author Peng, Terrance
Hamann, Heidi A.
David, Elizabeth A.
author_facet Peng, Terrance
Hamann, Heidi A.
David, Elizabeth A.
author_sort Peng, Terrance
collection PubMed
description
format Online
Article
Text
id pubmed-8983342
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89833422022-04-07 Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States Peng, Terrance Hamann, Heidi A. David, Elizabeth A. JTO Clin Res Rep Commentary Elsevier 2022-02-25 /pmc/articles/PMC8983342/ /pubmed/35400082 http://dx.doi.org/10.1016/j.jtocrr.2022.100302 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Peng, Terrance
Hamann, Heidi A.
David, Elizabeth A.
Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title_full Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title_fullStr Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title_full_unstemmed Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title_short Stigma May Exacerbate Disproportionately Low Guideline-Concordant Treatment Rates for Patients With Advanced-Stage Lung Cancer in the United States
title_sort stigma may exacerbate disproportionately low guideline-concordant treatment rates for patients with advanced-stage lung cancer in the united states
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983342/
https://www.ncbi.nlm.nih.gov/pubmed/35400082
http://dx.doi.org/10.1016/j.jtocrr.2022.100302
work_keys_str_mv AT pengterrance stigmamayexacerbatedisproportionatelylowguidelineconcordanttreatmentratesforpatientswithadvancedstagelungcancerintheunitedstates
AT hamannheidia stigmamayexacerbatedisproportionatelylowguidelineconcordanttreatmentratesforpatientswithadvancedstagelungcancerintheunitedstates
AT davidelizabetha stigmamayexacerbatedisproportionatelylowguidelineconcordanttreatmentratesforpatientswithadvancedstagelungcancerintheunitedstates

Ejemplares similares